$Sangamo Therapeutics (SGMO.US)$ This is the new medicine. G...

This is the new medicine. Gene Therapies will save the heathcare systems of the world Trillions in the future.

Pfizer's Hemophilia B treatment already approved is just the beginning. GLTA.

"Internal CSL figures estimate that between annual bleed rates and required therapies to address hemophilia B, a patient with the disease can cost an insurer $20 million over the course of their life. That puts the expenditure of $3.5 million for a gene therapy to reverse or cure the condition into perspective. When that is extrapolated out, HEMGENIX could save the U.S. healthcare ecosystem tens of billions of dollars over the next 20 years, Lojewski said."